Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2657
Gene Symbol: GDF1
GDF1
0.010 Biomarker disease BEFREE Of all GD, 12% (95% CI 2-42%) likely had spontaneous remission, 56% (95% CI 34-76%) required only antithyroid drugs, 22% (95% CI 13-32%) needed additional RAI, and 11% (95% CI 0.9-29%) underwent definitive surgery. 31452116 2020
Entrez Id: 54658
Gene Symbol: UGT1A1
UGT1A1
0.010 GeneticVariation disease BEFREE This mechanistic study sheds light on the pathogenesis of MMI-induced hepatotoxicity and prompts personalized prescription of MMI based on UGT1A1*6 genotype in the management of GD. 31740989 2020
Entrez Id: 6050
Gene Symbol: RNH1
RNH1
0.010 Biomarker disease BEFREE Of all GD, 12% (95% CI 2-42%) likely had spontaneous remission, 56% (95% CI 34-76%) required only antithyroid drugs, 22% (95% CI 13-32%) needed additional RAI, and 11% (95% CI 0.9-29%) underwent definitive surgery. 31452116 2020
Entrez Id: 7137
Gene Symbol: TNNI3
TNNI3
0.010 Biomarker disease BEFREE This case demonstrates the importance of ECG and cTnI screening among GD patients. 30503299 2020
Entrez Id: 10848
Gene Symbol: PPP1R13L
PPP1R13L
0.010 Biomarker disease BEFREE Of all GD, 12% (95% CI 2-42%) likely had spontaneous remission, 56% (95% CI 34-76%) required only antithyroid drugs, 22% (95% CI 13-32%) needed additional RAI, and 11% (95% CI 0.9-29%) underwent definitive surgery. 31452116 2020
Entrez Id: 3898
Gene Symbol: LAD1
LAD1
0.010 GeneticVariation disease BEFREE The aim of the present study was to analyse a possible association of three autoimmune disabilities - Multiple sclerosis (MS), LADA diabetes and Graves' disease (GD) with single nucleotide polymorphism (SNP; rs1990760) in the IF IH1 gene (also known as a melanoma differentiation-associated protein 5 - MDA5) within the Polish population. 31733941 2020
Entrez Id: 53358
Gene Symbol: SHC3
SHC3
0.010 Biomarker disease BEFREE Of all GD, 12% (95% CI 2-42%) likely had spontaneous remission, 56% (95% CI 34-76%) required only antithyroid drugs, 22% (95% CI 13-32%) needed additional RAI, and 11% (95% CI 0.9-29%) underwent definitive surgery. 31452116 2020
Entrez Id: 847
Gene Symbol: CAT
CAT
0.010 Biomarker disease BEFREE Our findings incriminate the MDA in the autoantibodies reactivity to oxidatively modified CAT leading to a disturbed oxidative profile and/or the progression of GD pathology. 31617239 2020
Entrez Id: 10993
Gene Symbol: SDS
SDS
0.010 Biomarker disease BEFREE Compared to control subjects, children with GD had higher thyroid volume SDS (P = 0.001), hsCRP (P= 0.001), TRAbs (P = 0.001) and sCD40L (P = 0.001).. 31782290 2019
Entrez Id: 9863
Gene Symbol: MAGI2
MAGI2
0.010 GeneticVariation disease BEFREE The genotypes of rs2160322 in MAGI2 showed a borderline association with AITDs (P = 0.048), and they had a strong correlation with GD (P = 0.012). 30535759 2019
Entrez Id: 169026
Gene Symbol: SLC30A8
SLC30A8
0.010 Biomarker disease BEFREE The incidence of GADA and ZnT8A in patients with GD is high and might indicate wide range endocrine autoimmunity, as well as risk for non-autoimmune diabetes rather than exclusively mark beta cell autoimmunity and type 1 diabetes. 30783963 2019
Entrez Id: 9575
Gene Symbol: CLOCK
CLOCK
0.010 GeneticVariation disease BEFREE Clock gene <i>PERIOD3</i> polymorphism is associated with susceptibility to Graves' disease but not to Hashimoto's thyroiditis. 31328557 2019
Entrez Id: 7516
Gene Symbol: XRCC2
XRCC2
0.010 GeneticVariation disease BEFREE Here, we report a case of a 56-year-old woman heterozygous for XRCC2 mutation with a history of Graves' disease and bilateral breast carcinomas, who was found to have a diffusely infiltrative extra-axial mass in the high parietal convexity with infiltration into the adjacent superior sagittal sinus. 31603477 2019
Entrez Id: 100313837
Gene Symbol: MIR762
MIR762
0.010 AlteredExpression disease BEFREE Among them, miR-16-1-3p, miR-122-5p, miR-221-3p, and miR-762 were upregulated in GD (P < 0.001). 30949910 2019
Entrez Id: 407010
Gene Symbol: MIR23A
MIR23A
0.010 AlteredExpression disease BEFREE GD Tregs exhibited weaker suppressive activity, miR-23a-3p mimic suppressed SIRT1 expression and suppressive-activity of Tregs whereas it promoted the expression and acetylation level of FOXP3 in the GD group. 30391932 2019
Entrez Id: 2212
Gene Symbol: FCGR2A
FCGR2A
0.010 AlteredExpression disease BEFREE The cell percentages expressed CD32 and protein expressions of CD32 on PBMCs, and monocytes from patients with active GD were significantly reduced compared to controls and patients with remissive GD. 31033004 2019
Entrez Id: 6373
Gene Symbol: CXCL11
CXCL11
0.010 Biomarker disease BEFREE A Th1 immune-preponderance has been shown in the immunopathogenesis of autoimmune thyroiditis (AT), Graves' disease (GD) and Graves' Ophthalmopathy (GO), in which the Th1-chemokines (CXCL9, CXCL10, CXCL11), and their (C-X-C)R3 receptor, have a crucial role. 31813786 2019
Entrez Id: 10148
Gene Symbol: EBI3
EBI3
0.010 Biomarker disease BEFREE Our preliminary observations indicate that IL-35 and CD4+P35+Ebi3+T cells may be involved in the pathogenesis of GD. 30938833 2019
Entrez Id: 2213
Gene Symbol: FCGR2B
FCGR2B
0.010 AlteredExpression disease BEFREE In particular, the expression of CD32B on PBMC was also decreased in active GD patients. 31033004 2019
Entrez Id: 9739
Gene Symbol: SETD1A
SETD1A
0.010 AlteredExpression disease BEFREE The expressions of HMTs (SUV39H1 and SUV39H2) at the mRNA level were significantly decreased in PBMCs from GD patients compared with healthy controls (P<0.001), whereas the SETD1A expression at the mRNA level was significantly increased in GD patients compared with healthy controls (P=0.004). 31341471 2019
Entrez Id: 9103
Gene Symbol: FCGR2C
FCGR2C
0.010 AlteredExpression disease BEFREE The cell percentages expressed CD32 and protein expressions of CD32 on PBMCs, and monocytes from patients with active GD were significantly reduced compared to controls and patients with remissive GD. 31033004 2019
Entrez Id: 6863
Gene Symbol: TAC1
TAC1
0.010 Biomarker disease BEFREE GD = Graves disease; hCG = human chorionic gonadotropin; MMI = methimazole; PPT = postpartum thyroiditis; PTU = propylthiouracil; T3 = triiodothyronine; T4 = thyroxine; TBG = thyroxine-binding globulin; TRAb = TSH receptor antibody; TSH = thyroid-stimulating hormone. 30289300 2019
Entrez Id: 5054
Gene Symbol: SERPINE1
SERPINE1
0.010 AlteredExpression disease BEFREE Induction of plasminogen activator inhibitor-1 (PAI-1, SERPINE1), a clade E member of the serine protease inhibitor (SERPIN) gene family and a prominent regulator of the pericellular proteolytic microenvironment, was one of the most highly up-regulated proteins in INF-γ- or TGF-β1-stimulated GO fibroblasts as well as in severe active GD compared to patients without thyroid disease. 30414981 2019
Entrez Id: 5536
Gene Symbol: PPP5C
PPP5C
0.010 Biomarker disease BEFREE GD = Graves disease; hCG = human chorionic gonadotropin; MMI = methimazole; PPT = postpartum thyroiditis; PTU = propylthiouracil; T3 = triiodothyronine; T4 = thyroxine; TBG = thyroxine-binding globulin; TRAb = TSH receptor antibody; TSH = thyroid-stimulating hormone. 30289300 2019
Entrez Id: 9832
Gene Symbol: JAKMIP2
JAKMIP2
0.010 GeneticVariation disease BEFREE CONCLUSIONS JAKMIP2 gene polymorphism require further study as potential risk factors for Graves' disease in the Chinese Han population. 30796769 2019